No insider purchase over the last 90 days. The latest was filed 28 Nov 2025.
This page follows insider dealings at iZafe Group AB as filed with Finansinspektionen, a company from the Health Care sector. 13 insiders have disclosed 15 filings since 18 October 2025.
Purchases and sales both appear in the filings: 3 purchases (2 insiders, €9,889) and 1 sale (1 insider, €27k). Netting one side against the other leaves €17k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 2 board members. Anders Segerström filed the largest sale, €27k, on 26 June 2026, which represents 0.23% of the company's market value.
With 15 filings in twelve months, the company is more active than the median of 7 filings across the 886 companies we follow on the same exchange. Over the whole record (from 2025), the tally stands at 5 purchases and 1 sale.
In all, 1 purchase was made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 28 November 2025, which is 324 days ago. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
17 of 17 declarations
iZafe Group AB is a company operating in the healthcare and pharmaceutical sector. It is listed on the XSTO stock exchange.